Planning

Transitional Medicines 6

NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)

This public procurement record has 1 release in its history.

Planning

10 Nov 2025 at 16:24

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

The NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, is in the planning stage of a procurement process for the "Transitional Medicines 6" tender. This tender is focused on pharmaceutical products, notably medicines soon to lose their patent exclusivity. The procurement, valued at approximately £15.9 million GBP, encompasses goods with key items such as Ferric Carboxymaltose, Pazopanib, Denosumab, and Apremilast. The location of supply is set within the region of Wales, United Kingdom. Current planning activities indicate that suppliers will be alerted to an upcoming opportunity on 18th November 2025, with future notices expected by 26th November 2025. The contract period is slated to begin on 1st March 2026 and conclude by 29th February 2028 with potential for extension.

This tender presents an excellent opportunity for businesses within the pharmaceutical sector to expand their reach and secure a contract with a significant public health authority. Companies specialising in generic medicines, particularly those suitable for transition due to patent expiration, stand well-positioned to compete for this contract. Furthermore, small and medium-sized enterprises (SMEs) may find this opportunity particularly accessible due to its suitability classification and the existence of a framework agreement, providing a structured and supportive procurement environment. Engaging in this tender process could lead to long-term business growth within the Welsh healthcare system's supply chain.

How relevant is this notice?

Notice Information

Notice Title

Transitional Medicines 6

Notice Description

This tender is for medicines which are shortly due to lose their patent exclusivity, including but not limited to Ferric Carboxymaltose; Pazopanib; Denosumab; Apremilast

Planning Information

This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts). There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published please contact Jennifer Tresilian (jennifer.tresilian@wales.nhs.uk).

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05de0d
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/072540-2025
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£15,902,104 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
10 Nov 20253 weeks ago
Submission Deadline
Not specified
Future Notice Date
26 Nov 2025Expired
Award Date
Not specified
Contract Period
1 Mar 2026 - 29 Feb 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Planning
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)
Contact Name
Jennifer Tresilian
Contact Email
jennifer.tresilia@wales.nhs.uk
Contact Phone
+442921501383

Buyer Location

Locality
NEWPORT
Postcode
NP10 8BE
Post Town
Newport
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL54 Monmouthshire and Newport
Delivery Location
TLL Wales
Local Authority
Newport
Electoral Ward
Tredegar Park and Marshfield
Westminster Constituency
Newport West and Islwyn

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-05de0d-2025-11-10T16:24:31Z",
    "date": "2025-11-10T16:24:31Z",
    "ocid": "ocds-h6vhtk-05de0d",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-NHS-RQF",
            "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
            "identifier": {
                "scheme": "GB-NHS",
                "id": "RQF"
            },
            "address": {
                "streetAddress": "Imperial Park Unit 5, Celtic Way",
                "locality": "Newport",
                "postalCode": "NP10 8BE",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKL21"
            },
            "contactPoint": {
                "name": "Jennifer Tresilian",
                "email": "jennifer.tresilia@wales.nhs.uk",
                "telephone": "+442921501383"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
                "classifications": [
                    {
                        "scheme": "UK_CA_TYPE",
                        "id": "publicAuthorityCentralGovernment",
                        "description": "Public authority - central government"
                    },
                    {
                        "scheme": "UK_CA_DEVOLVED_REGULATIONS",
                        "id": "GB-WLS",
                        "description": "Welsh devolved regulations apply"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-NHS-RQF",
        "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
    },
    "planning": {
        "milestones": [
            {
                "id": "engagement",
                "type": "engagement",
                "description": "This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts). There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published please contact Jennifer Tresilian (jennifer.tresilian@wales.nhs.uk).",
                "dueDate": "2025-11-18T23:59:59+00:00",
                "status": "scheduled"
            }
        ],
        "documents": [
            {
                "id": "072540-2025",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/072540-2025",
                "datePublished": "2025-11-10T16:24:31Z",
                "format": "text/html"
            }
        ]
    },
    "tender": {
        "id": "ocds-h6vhtk-05de0d",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Transitional Medicines 6",
        "description": "This tender is for medicines which are shortly due to lose their patent exclusivity, including but not limited to Ferric Carboxymaltose; Pazopanib; Denosumab; Apremilast",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33600000",
                        "description": "Pharmaceutical products"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKL",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amountGross": 19082525,
            "amount": 15902104,
            "currency": "GBP"
        },
        "mainProcurementCategory": "goods",
        "aboveThreshold": true,
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "lots": [
            {
                "id": "1",
                "suitability": {
                    "sme": true
                },
                "contractPeriod": {
                    "startDate": "2026-03-01T00:00:00+00:00",
                    "endDate": "2028-02-29T23:59:59+00:00",
                    "maxExtentDate": "2030-02-28T23:59:59+00:00"
                },
                "hasRenewal": true,
                "status": "planning"
            }
        ],
        "communication": {
            "futureNoticeDate": "2025-11-26T23:59:59+00:00"
        },
        "status": "planning"
    },
    "language": "en"
}